Clinical Trial Update: Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108 [Phase 1]

View source ↗

Summary

Phase 1 safety follow-up study of participants dosed with INV-347 in study INV-CL-108 for obesity is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• INV-347

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: RECRUITING